SYNAGIS 50 mg/0.5 mL
SYNAGIS is a clear, slightly opalescent solution in appearance. It is presented in a package containing 1 0.5ml vial. YNAGIS contains the active substance called palivizumab, which is an antibody that specifically acts against the virus called respiratory syncytial virus (RSV). Children are at an increased risk of illness caused by a virus known as respiratory syncytial virus (RSV). Children who are likely to have severe RSV disease include at-risk children, premature babies (35 weeks or less) and / or babies born with certain heart or lung problems. In summary, SYNAGIS is a medicine that helps your child or baby protect against severe RSV disease.
SYNAGIS 50 mg/0.5 mL You can contact us to find out the price:Contact for detailed information